COVID-19 Vaccine: The Top Two Stocks to Consider Immediately
The pandemic is only getting worse.
At the moment, there are nearly 40 million global cases, with 1.1 million deaths. In the U.S., the count...
This is Why Nio Inc. Could be Headed to $40, Near-Term
At this point, we wouldn’t be shocked to see Nio Inc. (NIO) at $40.
Since bottoming out in May 2020 around $3.20, the EV stock...
The Top Two Vaccine Stocks to Avoid
There’s no such thing as a perfect trial.
Fortunately, there are safeguards in place to stop trials in the event of a mishap. We’ve seen...
This Pandemic Stock Has Just Begun to Push Higher
Keep an eye on Altimmmune Inc. (ALT).
The stock is pushing higher thanks to more positive data on its COVID candidate.
The company just published positive pre-clinical...
Pay Close Attention to Shares of Apple
Pay close attention to Apple (AAPL) over these next few days.
We could easily see sizable momentum in the stock ahead of its October 13...
President Trump Pushing these Two COVID-19 Stocks Higher
Days after leaving the hospital, President Trump is urging regulators to approve emergency use authorization of Regeneron’s (REGN) and Ell Lilly’s (LLY) treatments.
He specifically...
The Top 3 COVID-19 Treatment Stocks to Watch
With the coronavirus showing no signs of slowing, the world is in desperate need for a treatment -- and fast. Thankfully, we may be...
The Telehealth Boom is Still Healthy — and Here to Stay
Telehealth is quickly disrupting the $11.9 trillion healthcare market, showing no signs of slowing. All as consumers opt to visit with physicians online rather...
Popular Post
